This website provides general information about Tai E. The information provided on this website does not constitute legal advice. All information, content, and materials available on this site are for general informational purposes only and do not necessarily represent the views of the firm or its clients. If you require legal and intellectual property advice, please do not hesitate to consult us. This website uses cookies to enhance your browsing experience. By continuing to use this website, you agree to our use of cookies. More about our Privacy Policy and Cookie Policy.

Our Teams Our Teams Our Teams
SELENE Y. J. CHIEN
Patent Attorneys / Patent Agents Biotechnology & Chemistry

SELENE Y. J. CHIEN

  • Section Chief of Domestic Patent Division
  • Patent Attorney (Cert. No. A0540)

Education

  • Master of Science in Toxicology at National Taiwan University, Taiwan
  • Bachelor of Science in Medical Technology at National Taiwan University, Taiwan

Specialization

  • Biochemistry
  • Molecular Biology
  • Oncology

Author

韓國最高法院放寬化合物多晶型專利的標準 抗體專利的可據以實施要件–由美國最高法院Amgen v. Sanofi案最終判決談起 次級專利對新藥專利佈局的重要性 藥品是否能透過修改仿單的適應症來避免侵權：以智慧財產及商業法院110年度民專訴字第9號判決為例 COVID-19病毒相關的智慧財產權豁免 歐洲專利局於審查基準新增抗體揭露方式之相關規定 COVID-19病毒相關的智慧財產權豁免

Experience

  • Senior IP Specialist at Phycos International Co., Ltd. and Phycos Intellectual Property Offices
  • Senior Assistant Manager at SyneuRx International (Taiwan) Corp.
  • Senior Patent Deputy Manager at Formosa Transnational Attorneys at Law
  • Patent Engineer at Wenping & Co. International Patent & Trademark Office

Other

Speech: 

 

Technical Fields (IPC/LOC) :

Back to List
Line Line
Line Line
Line Line
Line Line